Only 1 in 5 Overweight People Get Type 2 Diabetes. Here's Why | Scott Soleimanpour | 213
49 minAudio
Send us Fan Mail Short Summary: The science of diabetes with Dr. Scott Soleimanpour, blending personal insights and cutting-edge research that gets into mitochondrial biology and more. About the guest: Scott Soleimanpour, MD, is a physician-scientist at the University of Michigan, where he runs a lab studying pancreatic beta cell biology and mitochondrial quality control in diabetes. Note: Podcast episodes are fully available to paid subscribers on the M&M Substack and everyone on YouTube. Partial versions are available elsewhere. Full transcript and other information on Substack. Episode Summary: Nick Jikomes interviews Dr. Scott Soleimanpour about the biology of diabetes, exploring the pancreas’s dual role in digestion and blood sugar regulation via beta cells, which produce insulin. They discuss type 1 diabetes as an autoimmune condition with rising incidence and complex beta cell issues, and type 2 as a progressive disease tied to beta cell failure, not just obesity. The conversation covers mitochondrial function in beta cells, lifestyle factors like diet, and the limits of current treatments, offering practical advice for prevention and management. Key Takeaways: The pancreas has two parts: the exocrine (98%) makes digestive enzymes, while the endocrine (1-2%) regulates blood sugar with hormones like insulin from beta cells. Type 1 diabetes involves autoimmunity and intrinsic beta cell defects, with rates increasing due to environmental factors, not just genetics. Type 2 diabetes hinges on beta cell dysfunction, not obesity alone - only 1 in 5 overweight people develop it, showing other factors matter. Beta cells are energy-intensive and long-lived, relying on mitochondria; stress from overwork (e.g., excess insulin demand) can lead to failure. Current diabetes drugs don’t rejuvenate beta cells; only TZDs (rarely used) preserve function, highlighting a gap in treatment. Related episode: M&M #140: Obesogens, Oxidative Stress, Dietary Sugars & Fats, Statins, Diabetes & the True Causes of Metabolic Dysfunction & Chronic Disease | Robert Lustig *Not medical advice. Support the show Support my work: Good Chemistry: Personalized, science-based health consulting. Work with Dr. Nick Jikomes directly. Affiliate Partners: Visit this link to see my affiliate partners and get discounts codes for products & services to support health. For all the ways you can support my efforts.
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
This is a good idea. This is a good idea. This is a good idea.
This We really interested in the regulation of mitochondrial quality control are obviously key for understanding diabetes.
So let's just give everyone a very, very quick, very basic crash course in the pancreas and the beta cells in particular. What is the pancreas basically doing as an organ and how are beta cells working at a very basic level in a normal, healthy individual? Yes, great question. So I like to think of the pancreas as actually two organs together. So you have 98% of the pancreas that is what we call the exocrine pancreas. That's the parts of the pancreas that are responsible for making digestive enzymes that will be fed into the gut to help you digest food, like fats, especially in your food.
And then there's a whole interconnected series series of ducts, that collect those digestive enzymes and two percent of the pancreas are called the endocrine pancreas. That's what we study in my lab. And the endocrine pancreas is primarily organized into these structures called eyelets of longharrhons. And they're essentially micro organs that are made up of many different cell types that are kind of sprinkled throughout the pancreas.
And the different cell types in the eyelet release hormones that have a lot to do with the regulation of glucose levels in the body. You mentioned the beta cells. The beta cells in a human comprise maybe 40 to 50% of the cells in the eyelet. And they make insulin, which is the hormone that is really important for helping us metabolize glucose, getting glucose into our cells.
And then we have a lot of blood sugar, blood sugar starvation and the the like. So we have about one, you know, this is again a proximate. We have about a million eyelets in the pancreas of an adult human. And in a normal person, when you're eating a meal, and you have nutrients come into your body, those fuel stimuli raise your blood sugar, especially the carbohydrates as they're metabolized.
And that elevation in the blood sugar stimulates those beta cells to release insulin to go into the bloodstream so you can metabolize that sugar. So we can think of the pancreas as having two main parts. The bulk of the mass is actually devoted to making digestive enzymes. So those enzymes are manufactured there and there's some kind of distribution or piping system that then gets all those enzymes shipped out to our gut where they actually do the work of chewing up our food.
And then a smaller portion of the pancreas, but a very important portion is this endocrine portion. And this is where we start talking about hormones and insulin and we get into the diabetes biology and all that stuff. Exactly. Yeah. And insulin is not released into a duct network. - So these islets are really fast killer. They have a really substantial blood supply.-, one into the circulation and then they go into the job of metabolizing nutrients.
I do they have outsized vasculature because the very nature of what's going on here with insulin is to sense and respond and help regulate blood glucose levels. So I'd imagine it has got to be a very quick and sensitive mechanism there. Absolutely. Yeah. I mean, I think these are cells that need a lot of nutrients but then there are also cells that need to be rapid responders to what's going on in the body. So I think those are two prominent reasons why they're really vascularized cells.
And then we usually talk about two types of diabetes type one and type two. I know that you also have a personal connection here. So do you know to talk about that a little bit how you got into this and how that connects to the type one diabetes and what that is and maybe we'll talk about that for a bit before probably spending the bulk of our time on type two. Yeah, yeah, yeah, yeah, absolutely. Thanks for giving me the opportunity to talk about that. Yeah, so I was diagnosed with type one diabetes when I was five.
So, you know, not to give away my age but like we're approaching 40 years that I've had diabetes. And, you know, I was born and raised outside of Cleveland, Ohio, a small town called Youngstown, Ohio. And that kind of changed everything for me. So, you know, I was a, you know, just normal kid like to eat snack, maybe a little too much. And then all of a sudden I had two weeks of like this increasing kind of just not feeling well.
The story that I prominently remember, I don't remember much from that age was we ga a wetting. And I kept going to the bartender to ask for coge or pepsi or whatever. And because I was thirsty. So, I have a coke or pepsi, I would drink it. And then I'd run to the bathroom. And then I'd come back. And then my dad would see me going back for like more. And he was like stop drinking. Why are you drinking so much coke? And I was like, I'm thirsty. I don't know what to tell you.
Are you the thirsty for like a water or are you thirsty for something sugary? Probably a little bit of both. I will say that I can't give you like the greatest play by play of the inner workings of the five year old mind. But like for some reason in my head it, it was coke or pepsi that I really wanted. Could also just be that I was a kid at a wedding and was like, oh, I can have pepsi when I'm but you were you were unusually thirsty. Oh yeah, yeah, absolutely. And you know, then my folks were like, wait, there's something not right here. And you know, I was really interested in what was going on as much as a five year old could be. I really was back then when you got diagnosed with diabetes now. So I should also say I'm a physician who takes care of people with diabetes too.
When you diagnose folks with diabetes now, oftentimesny times they're in and out of the hospital very quickly. Sometimes you know, hours. But back then, there was this belief in the mid 80s that you know, you admitted the patient of the hospital and you had like intensive education and training and all these things. So I spent two weeks in a children's hospital in my hometown. Oh wow. And yeah. And so you know, I was in the ICU for a couple of days because my sugars were really bad.
But most of the time I was just in a pediatric floor. And so I started expressing an interest in like helping out, out with the staff, figuring out what else was going on. I just kind of that lit, that fire of interest in diabetes and medicine and the like. So that kind of changed everything. And I became very interested in knowing more about this disease. And I don't know, it's probably the way I was raised or whatever, but maybe being a midwestern kid, like if you have a problem, you have to fix it yourself. But I very much kind of drilled into this, you know, and I don't think it came from externally. I think this was just me. Diabetes was my diagnosis at a relatively young age. Is five years of age a normal age? What's sort of that distribution look like?
Yeah. I I mean, I think that, you know, typically it's somewhere between the five to 12 windows. So I was probably on the youngish end. But like that's that's prototypically in the old days like juvenile onset of diabetes. Like I was I was on the earlier kind of window of that, but still like kind of in this typical place for type one. So it's truly a childhood onset. It's not an adolescent thing normally. Yeah. I would say if you like looked at the numbers in detail of detail and said, what is the biggest population? But the thing that we know now about type one is that you can get diagnosed with type one throughout your lifespan. So, you know, I take care of people with type one. We have folks come into the clinic that get diagnosed with type one in their 20s, 30s.
40s. Is that because is that because they had it all along and it was a failure of the diagnosis or, you know, to pick it up? Or are people getting it at later ages as well? Yeah. Yeah so that's also a great question. I think that the more we learn about type one. There are a few things. So I think historically there were people that were like diabetes as you're an adult. But when you rigorously study some of these folks, it doesn't change the fact that their blood sugars are high, but it just changes the assumption you made when you met them, but when you when you measure production of your own insulin when you measure auto antibodies to see if there's an immune attack, then it starts to change the picture and then make you think, oh, you Now we know you can diagnose. There's clearly type two that gets diagnosed in childhood as well. So I think the age barriers have kind of slowly disintegrated away. Yeah. And while you get more type one in childhood and more type two and adulthood, the, you know, the age barriers, I think are kind of starting to change and we just look at like what's the clinical picture? What is the data tell us about what what the patient might have and I see. And then we have to kind of do our best.
us to try to fit people into a box, which is also sometimes challenging. Yeah, I would imagine so. So I mean, clearly there's there's always been a kind of bi-modal distribution here, right? There's a cluster of people who get it relatively young often in childhood. Those are almost always type one. The people who get it closer to adulthood are usually type two. So that probably gave rise to the presumption most of the time that if you were an adult, it had to be type two, even though not necessarily and vice versa. Then over time, I think there probably was some true.
blurring here because I suspect just as type two has become more common at younger and younger ages due to diet and lifestyle issues that happened earlier in life. I would imagine that maybe the autoimmune side of this or type one can happen later in life as history has progressed because there's probably things in our environment that can instigate that at later times in the used to. Yeah, I think that's that's a very fair way to put it and some of it is also changed based on our the evolution of our understanding of the diseases.
So as you said, you know, in the mid 80s, it was no type one or type two. It was juvenile onset and adult onset. And then we learned, oh, wait, you can get. Mammoth, you can get this picture in adulthood. Okay, we need to change the names. And then in the late 80s and early 90s, they started to call it insulin dependent because there were adults on insulin that did look like that. And then the insulin doesn't have the same type of diabetes. And so then later it evolved into type one diabetes, which again, most people think maybe some degree of autoimmunity and type two diabetes maybe some metabolic problems.
But I can tell you too, like personally, I have problems with those names too because they're learning more about these diseases. And so, you know, maybe it's a lot of. Discussion about nomenclature, but I think as we learn more about these diseases, it changes the way we view them and what causes them and yeah, what goes into it. Can you give us a brief overview of what we know on the pathogenesis of type one diabetes today, my understanding, someone who pays attention to this stuff, but it but it's not in the field and not, you know, I'm not up to date on a lurcher in this particular domain. I think historically the my understanding has been that type one is an autoimmune thing. Your immune cells attack your own pancreatic beta cells and destroy them. And then they're destroyed. And then you can't make your own insulin. Is that the full picture or is that incomplete?
So that is the perfect general distillation. And that's what I was taught in med school. And that's what our medical students learn here. And that is the view. But I give a lecture to our med students and then I kind of shake things up because it's it's not the full view. So what we're what we're learning from the genetics, the pathology, the histologic study of type one, the natural history is that yes, there's an immune component.
But that's not it. There's also an intrinsic beta cell problem that occurs in type one. I see. There's also some evolving work that the exocrine pancreas at the beginning, which I was like, oh, that doesn't do anything. Forget that. There also seems to be some evidence that there's problems in the exocrine pancreas in type one that might agitate the I mean interface and also contribute to to the disease. So I I think of type one, really, if you want to be fair as a multi organ disease, it's an or it's a disease of sick beta cells.
And then sick immune cells and potentially a sick pancreas writ large that then have these conversations that lead to overall beta cell loss. The other interesting thing is the beta cells themselves seem to not always fully disappear in type one. If you look under, you know, a microscope and we had the field is at the fortune to study autopsy specimens or or pancreas sections of folks that had type one and passed away and donated their organs for research and A lot of these folks sometimes people up to, like this patchy pattern where you'll have like some eyelets and some beta cells surrounded with like a small number of immune cells and then other eyelets, there's no immune cells at all.
So you know, it started to kind of change our view that it's not just all about the immune system. There's probably more to it. That you know, if you're talking to someone that isn't in the field that doesn't know much about diabetes and it's like, give me like two word autoimmune disease. Yeah, it's not wrong. But I think if you say, yeah, it's autoimmune disease, it's auto immunity plus these other things.
Right. So there's probably some intrinsic component here. Basically some people are just born beta cells that aren't quite functioning in the fully normal way. Maybe the other part of the pain creases sort of leaking enzymes over there and that's aggrav but the discovery of the diversity of these probable abnormal peptides likely coming from a beta cell source.
That kind of mists educate the immune system or are educating just fine. But then you have abnormal cells in the thymus that normally they would, you know, we call them auto reactive T cells. They normally would be cleared and you wouldn't kill your beta cells. But for some reason these auto reactive T cells are hanging around and then they go and attack the beta cells. So, yeah, you know, I think it's pretty safe to say that like hybrid forms of insulin, insulin peptides are part of it, but there's probably more to the story and and you know, the challenges kind of how you identify all of those very unique peptide energies, but really phenomenal immunologists trying to figure all that out.
Have the rates and obesity rates worldwide are on the rise and those things are not wrong.
Oh boy, what are you about to say? Type 1 diabetes incidence is also on the rise. It's not maybe on the steepness of the growth, not saying that. But, you know, but that would say, you know, if hopefully I'm not charactering too much, if sort of one of the old views was, this was like a fully intrinsic, you're born with a type of thing, you would not expect to see Absolutely. And then if you look at these, you know, historic, but I think, I think very powerful monoxotic twin studies.
And, you know, they give you this idea that there is an environmental component to type 1 and a genetic one. So, you know, the old studies suggest that if you have one twin that gets type 1, foundations, the other identical twin has a rate of getting type 1 at about 50%. and, there are some people that think that we might have underestimated those because maybe we didn't study those, the other twin long enough, and it could be even as high as 70%. But, if it was fully genetic, then it would be 100%. The other twin get type 1. It's not.
So, it's still largely genetic because there's huge genetic component because it's way more in the background rate, but it's definitely not 100%. Right. Right. And, and is the environmental component part of the reason why the incidence is rising? It's very possible. And, and that's also, you know, there are lovely studies studies like, the environmental triggers are still, you know, really intensely being studied and there's a lot that we really don't know.
Yeah. And, I mean, we don't necessarily need to get into it. It sounds like it's still fairly mysterious, but immediately that makes me think of just the general rise in auto-immunity that we've seen for some number of decades now. This would seemingly be related to that. It's just a piece of that puzzle. Why? Why are immune systems developing and being trained differently over time? Yeah. And, if I had the answer for that question, then I probably would be living on some fancy private island or something. Right. But, like, you know, we don't know. You know, there is some, you know, I think good evidence, that certain, you know, viral proteins are found in, eyelids of folks that have type one. There are certain, you know, sophisticated immunologic studies that show viral proteins in the eyelid or in these immune cells that are attacking eyelids. That make you think that, you know, certain viral types might give rise to it as an as an environmental trigger. I think that most people would say that's not unreasonable to think that. But, like, if you ask somebody, will tell me this specific virus type?
Yeah. Or which viruses? Then it gets a little murky. So I some, some folks think there's good information on anaeroviruses. Coxacky virus has been like linked to type one going back 30, 40 years. No one is just proven Coxacky virus involvement. I think people still believe that that's a possibility. And then, you know, there are other environmental things that people have discussed. But, like, you know, how strong the evidence is, I don't really know. Like, cows milk, antigen was one of them for a while. And it's like, oh, when did you feed your young one, milk, when? Right. You know, I don't know how strong that data, those data are, but I know the' the folks that are doing Teddy and the like, they're trying to find strong links in the environment too, because they realize it's more than the genetics, even if the genetics are a big part of it. Yeah. Yeah. So the bottom line is type one diabetes is on the rise to some extent.
It's not as common as type two. It might not be rising as fast as fast as type two, but it's not a purely genetic phenomenon. Right. Okay. So, and just to put on, and then to this section, so the sort of end problem with type one is that the beta cells get destroyed to some extent. And so the body's capacity to actually make and secret insulin is what is compromised. Yeah. Absolutely. And, you know, so our patients with type one, you know, require lifelong insulin replacement therapy. And, you know, we live in an era now where you can get insulin, you know, from pumps and but you can take in, you know, the old school ways, you take a shot, you know, under the skin and different forms of insulin and checking your blood sugar. And that's still the backbone of therapies ever since insulin was discovered over a hundred years ago. But, you know, we're moving towards an era hopefully in the next few years of maybe more automated insulin pump technologies and then even into the science fiction, hopefully science fact of maybe stem cell replacement of do those beta cells for type one are the beta cells constantly trying to regenerate themselves, are they dividing and then the means of them just keeps attacking them or do they just sort of permanently go away and they don't reject another really good question that it's hard to answer because when we get the tissue from a deceased donor, it's hard to know.
Right. Was this like a new beta cell or was this an old one that managed to like hide and evade all these years? Yeah. There's been a lot of speculation about like what is those origin story of those beta cells that are still there? Yeah. There are there are some there's some good evidence to support that, you know, there's also some evidence that maybe there is some regenerative signals. But again, is it one or is it both, is it a little bit of everything?
It's hard to know, but it just give some ideas in terms of like maybe maybe things that you could do. Is there potential for endogenous regeneration? Would that be sufficient? Who knows? If you were to try to stimulate endogenous regeneration, do you need to camouflage those cells? Because the immune system is still around. Right. You know, these are things that we're actively trying to figure out. And I don't think people quite know mostly because you know, you can't and you rightly shouldn't be able to you can't do that like from someone with diabetes, right? That's it. And And this is an organ that you can't really study in real time. So.
So turning to type two diabetes, I'll kind of let you steer us in the beginning here. You know, what is type two diabetes? Are there multiple subtypes? How do you start to think about this You know, I always give everyone the preface that yes, I'm a beta cell biologist. And so you know, a a lot of people are always like, well, the thing, well, the thing that you study is centered at your universe. That must be why you study it.
But as a kid with diabetes, I got to beta cells because I I thought they were you know obesity is definitely part of the equation. Like, you know, no, no.
I'm not going to dispute that. But there are some interesting peculiarities when you sort of look in the clinical space that make you wonder like, why do you get type two? So here's a couple of them. One of them is if you look in the US, the approximately one and two people are considered overweight. Okay. If you look in the US, one in 10 people have type two diabetes or have diabetes and vast majority of them have type two diabetes.
So here's the here's the interesting thing. The majority of people that are overweight or that have type two diabetes are also overweight. So I'll do a quick distillation of the math and say, all right, if 50% of the population is overweight, 10% have type two, then in a reductionist way, one out of every five overweight people have type two diabetes. But turn that number on its head. That also means four out of every five people. Only you could say only one and five. Why isn't it five? Exactly. So four out of five people that are overweight don't have diabetes.� And then you could say well, oh you haven you haven't studied 3.5 for a long time. But like these are like long, long, the longitudinal, like looks, looks at our population.
It's not these and these things are pretty constant. So what then what is up with those four people that don't get diabetes versus the one person that does? And this is where I say the beta cells matter. If you're overweight, you have obesity in both in all the cases, the folks with type two diabetes have a beta cell problem. Yeah. They have beta cell failure burnout, loss of function, however you want to term it. And so this and then really elegant work that was done in Seattle in the late 90s, early 2000s, kind of really solidified this study, this effect in human, in the humans, in studies in humans, that the folks that get type two diabetes develop an intrinsic beta cell problem that their beta cells can't compensate that appropriately for their relative degree of insulin resistance that's driven by their relative degree of obesity. So this is a beta cell disease. Yeah. I guess another way of saying all that is obesity in itself cannot possibly be the driver of type two diabetes. Right. Exactly.
There's also a couple other very interesting things. Again, I distilling large quantities of work done. The vast majority of the genetic low-ci associated with type two diabetes and there are a lot, there's probably 400, maybe up to 500 different low-ci, many of which have very small contributors to the disease. But the vast majority of them encode products that have key beta cell functions. I see. So the genetics kind of push us to the beta cell. And to me, I think one of the most fascinating things, and this is, I regularly cite this study when I talk to students or if I go on the road to give a talk to a wider diabetes audience. A study done in the UK led by a guy named Roy Taylor. This is done in the pre-ozemic era, but it was published in 2018 and they took early onset type two diabetes patients who were overweight and either with intensive diet or surgery treated these patients to bring their body weight into the normal body weight range. They were no longer overweight. And here is the fascinating thing. The patients split into two groups about 50-50.
50% of the people, their blood sugars fell into the non-artificial range, so you could call them responders to the weight loss. The other 50% they still had diabetes. They were non-responders. Both groups had identical liver fat reductions, pancreas fat reductions, weight loss was similar amongst the groups. All of these things were the same. The difference between them, the responders and the non-responders that stayed with diabetes, the non-responders didn't recover beta cell function.
The ability to create insulin to a glucose child. So it comes back to the beta cells again. And just to summarize what we've said so far, it sounds like what you're saying is, so obesity is neither necessary nor sufficient for someone to have diabetes. You can be obese and not have diabetes. You can also be lean or not obese and have diabetes. So there there might be common drivers, which is why there's a correlation. There's a relationship between obesity and diabetes, but it's certainly not one-to-one. Right precisely. And that's not to say that if you have type 2 and you're overweight, that losing weight and eating right isn't going to help you.
That would be an insane thing to say. In our clinic, we definitely advise lower weight, exercise, diet, reduced carbon take, all those things. That is literally the backbone of type 2 diabetes treatment. But the thing that we always remind our patients is, that's a start. And if you're lucky, yes, maybe it'll get you off all your diabetes medications, but there's a good chance it won't, and then when it won't, then we talk about other medical approaches to treat you.
So let's talk about beta cells in insulin a little bit. So type 2 diabetes, to what extent? This is something that I'm a little confused on. I don't know if this is known, known, and I'm just ignorant, or or this is still being worked out. So to what extent is type 2 diabetes an issue of insulin secretion by the beta cells versus insulin resistance elsewhere? So we talked a little bit about diabetes subtypes too. And I will say there is this evolving look at type 2 diabetes to break it down to sub types also. I would have to remind myself there are these four-letter acronyms for the different sub Types of type 2. I'm still trying to get my head around them. They're very helpful when we talk in the molecular space. I will say I I haven't gotten to the point of my clinic where I'm breaking them.
down into these categories. But there are folks with type 2 that definitely don't have autoimmunity, and they're definitely severely insulin deficient. And then there are folks with type 2 that have severe insulin resistance. And they're part of that whole subgroup. And then those two are probably like smaller components of type 2 they're not the so in the in the garden variety in those two sub types, you know probably you know and there's certainly some correlation with continued waking but most to most degree the insulin resistance tends to plateau. And then you get some degree of beta cell dysfunction.
But you know in large part most of the time diabetes is a progressive disease. So you know you see someone with garden variety type 2 you start them on say a medicine like metformin and then you follow the person for 10-20 years and then in 20 years they're on like multiple drugs and maybe an injection or maybe even on insulin and that that progression is likely related to like continued beta cell loss with time. So they're both factors the insulin resistance probably starts first.
You know early on in the disease process and the beta cell is probably trying to figure out how to deal with it and then at some level at some point it just can't anymore. I see I can't make more insulin, can't can't figure it out anymore. I see so so in some sense in the abstract maybe loosely we could you know there's insulin resistance to some extent somewhere the beta cells are trying to keep up with that so to speak and they kind of get burned out in some way shape or form.
Maybe send me a note and get disappointed in me. There is I will say there is a community of folks as well and it's not like one or two people there's like a decent number of folks in our field field also. I would say this is the commonly held by the way but to be totally fair there are some people that think that insulin resistance is actually its it's origin come from the beta cell too so that some people think that actually like an intrinsic problem in the beta cell is like over release of insulin that then starts the cascade of peripheral insulin resistance everywhere and then starts this back and forth feedback that then leads to eventual beta cell loss and diabetes diagnosis so it may not just be a simple simple as like oh you had too many too much junk food food and then you just got obese and then the you know the adipocytes and the muscle cells and the liver were were wearing your beta cells down there are some people that think oh there was a mess up beta cell hypersecreting early on that set off this insulin resistance as well so I just want to be totally fair to say there each other there are some folks that there are some folks that think that the origin of insulin resistance actually itself might be with the beta cell too and when we talk about insulin resistance is there are there any patterns of so so many many many tissues are insulin sensitive they have insulin receptors my understanding is insulin resistance is often tissue specific you might have some organ or tissue systems that are insulin resistant some that are insulin sensitive these can change over time is there are there any common patterns where certain organs tend to become the most insulin resistant early or you know is this this is tend to start with the liver or start with the whatever what do we know there yeah so now now I'm a little bit out of my comfort zone because I'm a beta cell person I will say that um you know it is believed that the muscle is the one that takes up and processes the vast majority of glucose are bloodstreamed and so so insulin resistance from the muscle probably exerts like a very prominent effect on overall uh systemic insulin resistance yeah yeah um but you know I think that the usual suspects of like the cell types that we think of that are most reliant on insulin for glucose uptake our muscle white adipocytes white you know are normal fat cells and the liver um and um uh you know and in the case of the liver you know it's it's not insulin insulin related glucose uptake貸 it's more insulin related you know glucose processing but in in the adipocytes and in muscle it's insulin related glucose uptake being you know prominent I'd say but I'd say muscle does most of the glucose metabolism yeah it's the natural yeah I mean you would naturally think that's gonna plant out size role because yeah it's I mean it does plant out size role it's it's in terms of like you know uh how does it you know do some come and go and some have differing kind of features doing the process I just I have to plead my ignorance with yeah it's very possible that that they do and I just I just don't know yeah so um I'll I there's all there's a there's a lot of complexity here obviously I'll let you kind of steer us but dietary food components so things like we're supposed to consume food um the foods and the things that we're consuming uh uh that we're supposed to be consuming and then things we might be things we might be consuming they're not supposed to be things like endocrine disruptors and chemicals and stuff like that when we think about type two well let me just put it this way one of the sort of common cartoon caricatures out there fortyte type two diabetes comes from is to be the same thing this is the we we all try to like, understand the world in simple ways right that that's the way that we are kind of wired um is that in easy way to apply to the world in a way that's true and we're going to be able to do that and we're going to be able to do that and we're going to be you know body weight being a being a balance of caloric intake and and and weight loss mattering then certainly there's a component to that but as you mentioned you know there's also an intrinsic component like some people the full version of this episode is available to paid subscribers at the mind and matter sub stack at mind and matter dot sub stack dot com the full version is also freely available on my youtube page just look up mind and matter or my name nicked your comis on youtube and you'll find the episode there this is a partial version of the episode and so it'll cut off partway through but you'll still get a significant portion so sign up to become me pay subscriber at sub stack or product containing 75 vitamins minerals and whole food sourced ingredients with less than one gram of sugar per serving no nasty chemicals or artificial anything it's gluten and dairy free and compatible with paleo vegan vegan vegetarian and ketogenic diets. AG1 is a quick and convenient way to supplement your diet to help ensure your body is getting the nutrients it needs it comes in powder form and you can mix it in water and drink it or you can put it into a smoothie or a shake or something like that i mix it into water and drink it and it's super convenient if you go to athletic greens dot com slash mind and matter athletic greens will give you a free one year supply of vitamin D and five free travel packs with sort of purchase their vitamin D product comes in tincture form so you just take one drop each day a large fraction of the population is actually vitamin D deficient especially in winter months when we get less sun exposure and vitamin do is super important for the proper function of the immune system and for a variety of other things so visit athletic greens dot com slash mind and matter or click the link in the episode description you'll get a free one year supply vitamin D with your first purchase
Send us Fan Mail At 93, Artemis Simopoulos explains why oils once used in paint now dominate the food supply, how a high omega-6 intake slows the making of EPA and DHA, and why cholesterol-lowering corn oil did not...
Send us Fan Mail Keith Baar explains why tendons stop adapting after 10 minutes of loading, why long low-load holds beat fast reps for connective tissue, and how vitamin C, collagen, caffeine and mTOR shape training....
Send us Fan Mail Dr. Stephen O'Rahilly explains GDF15, a stress hormone that makes us feel sick and eat less, and why morning sickness, and its severe form hyperemesis gravidarum (HG), comes from GDF15 made by the...
Send us Fan Mail Robin Carhart-Harris explains why his trial of psilocybin therapy vs. the SSRI escitalopram for depression missed one primary measure but favored psilocybin on almost everything else, and why SSRIs can...
Send us Fan Mail Nick talks with Prof. Gary Lewin (Max Delbrück Center, Berlin) about naked mole-rats, which in lab tests survived 18 minutes in pure nitrogen by shutting down brain activity, keeping the heart beating,...